Evidence map›Paper›PMID 41484440›Full record

ReviewBioprocess and biosystems engineering2026

Mixed sugars to a multipurpose chemical: perspectives of 2,3-butanediol fermentability in complex lignocellulose hydrolysates.

N Vignesh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

N VigneshDepartment of Bioengineering, National Institute of Technology Agartala, Barjala, Jirania, 799046, West Tripura, India. nvignesh.be@faculty.nita.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2,3-Butanediol (2,3-BDO) is recognized for its industrial competitiveness and is predominantly produced in its enantiomerically pure form via microbial fermentation. The economical production of 2,3-BDO relies on the effective use of complex lignocellulosic materials and the advancement of inhibitor-resistant microbial strains. The robust expression of 2,3-BDO dehydrogenase in bacteria enhances volumetric productivity in inhibitor-rich lignocellulose hydrolysate. For instance, isolation of an inhibitor-resistant Klebsiella pneumoniae from palm oil effluent facilitated the synthesis of 75 g L⁻¹ of 2,3-BDO through separate hydrolysis and fermentation process. Conversely, the electrochemical detoxification of sugarcane bagasse hydrolysate increased the production of 2,3-BDO to 114.3 g L⁻¹ in Enterobacter aerogenes. Furthermore, deletion of glucose transporter (ptsG) in 2,3-BDO-producing bacteria mitigated carbon catabolite repression (CCR). Adaptive evolution of Paenibacillus polymyxa in non-detoxified wheat straw hydrolysate enhanced 2,3-BDO productivity to 0.72 g L⁻¹ h⁻¹. However, the rational engineering of yeast is complex, encompassing the heterologous expressions of xylose metabolism, 2,3-BDO dehydrogenase, and the deletion of the Crabtree effect. Nevertheless, partial disruption of the Crabtree effect in polyploid Saccharomyces cerevisiae resulted in increased production of 2,3-BDO (132 g L⁻¹) during the fed-batch fermentation of cassava hydrolysate. This review paper discusses the benefits and drawbacks of 2,3-BDO metabolism in both bacteria and yeast. The paper seeks to clarify the differences in 2,3-BDO production between detoxified and non-detoxified lignocellulosic hydrolysates. Further, the study illustrates the importance of generating 2,3-BDO from untreated lignocellulose via the development of microbial consortia. Economic factors that facilitate the commercialization of 2,3-BDO fermentation have been discussed in detail.

Indexed as

Butylene GlycolsFermentationLigninHydrolysisKlebsiella pneumoniae2,3-butylene glycolButylene GlycolsLigninlignocellulose2,3-butanediolCarbon catabolite repressionCo-cultivationCo-fermentationDetoxificationMetabolic engineering

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.